Indivior Pharmaceuticals (INDV) Interest & Investment Income (2024 - 2026)

Indivior Pharmaceuticals' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 25.0% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $21.0 million (up 5.0% YoY), while the FY2025 annual figure was $22.0 million, down 4.35% from the prior year.
• Interest & Investment Income was $3.0 million for Q1 2026 at Indivior Pharmaceuticals, down from $6.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $7.0 million in Q1 2024 to a low of $3.0 million in Q1 2026.
• Historically, Interest & Investment Income has averaged $5.3 million across 3 years, with a median of $6.0 million in 2024.
• Biggest YoY gain for Interest & Investment Income was 20.0% in 2025; the steepest drop was 42.86% in 2025.
• A 3-year view of Interest & Investment Income shows it stood at $5.0 million in 2024, then gained by 20.0% to $6.0 million in 2025, then tumbled by 50.0% to $3.0 million in 2026.
• The last three Interest & Investment Income figures came in at $3.0 million (Q1 2026), $6.0 million (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.